Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

Abstract Background Migraine is a common and incapacitating condition, with severe impact on the quality of life (QoL) of the afflicted and their families, and negative economic consequences through decreased workforce participation, reduced functional ability and elevated healthcare costs. This stu...

Full description

Bibliographic Details
Published in:The Journal of Headache and Pain
Main Authors: Amanda Hansson-Hedblom, Isabelle Axelsson, Lena Jacobson, Joakim Tedroff, Fredrik Borgström
Format: Article
Language:English
Published: BMC 2020-08-01
Subjects:
Migraine
Headache
onabotulinumtoxinA
Botox
Cost-effectiveness
Cost of illness
Online Access:http://link.springer.com/article/10.1186/s10194-020-01162-x

Internet

http://link.springer.com/article/10.1186/s10194-020-01162-x

Similar Items